Clinical trial

Clinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders

NCT05656469

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2023-02-23

PhaseNA

Study timeline

Study start (actual)2023-02-23Date precision: day

Registry last updated2026-06-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Mood Disordersunresolved

Anxiety Disordersunresolved

Psychotic Disordersunresolved

Interventions

Personalised medication advice based on pharmacogenetic testingOTHER

Sponsors & collaborators

Parnassia Groeplead sponsor

Parnassia Psychiatric Institutecollaborator

University of Belgradecollaborator

University of Bonncollaborator

Babes-Bolyai Universitycollaborator

State University of New York - Upstate Medical Universitycollaborator

Ludwig-Maximilians - University of Munichcollaborator

King's College Londoncollaborator

University of Barcelonacollaborator

Maastricht University Medical Centercollaborator

Mapped research locations

BarcelonaSpain1 LondonUnited Kingdom1 AmsterdamNetherlands1 MünchenGermany1 SyracuseNew York, United States1 BelgradeSerbia1 Cluj-NapocaRomania1 BonnGermany1 MaastrichtNetherlands1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05656469 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.